PRWeb.com Press Release Feed - PRWeb Press Release Account Feed http://www.rsspad.com/rss2a/53325.xml PRWeb.com Press Release Feed - Press Releases en xml@emediawire.com xml@emediawire.com 30 Immunitor's Follow-up Study Shows Extended Survival of AIDS Patients in Terminal Stage http://www.prweb.com/releases/2005/10/prweb292445.htm Immunitor Company today announced that the results of the three-year follow-up study of its therapeutic HIV vaccine, V-1 Immunitor (V1), showed a dramatic survival benefit in patients at the final stage of AIDS. Compared to untreated control group V1 has extended life expectancy by nearly sixteen times. The study was just published in a special September issue of Biomedicine and Pharmacotherapy featuring new approaches in chemotherapy and immunotherapy of HIV/AIDS. (PRWeb Oct 3, 2005)

Read the full story at http://www.prweb.com/releases/2005/10/prweb292445.htm

]]> Mon, 03 Oct 2005 07:00:00 GMT http://www.prweb.com/releases/2005/10/prweb292445.htm Immunitor Publishes Placebo-Controlled, Phase II Trial of Its Therapeutic AIDS Vaccine http://www.prweb.com/releases/2004/12/prweb186195.htm Immunitor USA Inc., today announced that its licensed vaccine candidate V-1 Immunitor (V1) has shown promising results in Phase II, placebo-controlled, clinical trial involving 47 HIV-infected individuals. The study was published in the special December issue of the Journal of Clinical Virology – the official journal of The Pan American Society for Clinical Virology and The European Society for Clinical Virology. (PRWeb Dec 8, 2004)

Read the full story at http://www.prweb.com/releases/2004/12/prweb186195.htm

]]> Wed, 08 Dec 2004 08:00:00 GMT http://www.prweb.com/releases/2004/12/prweb186195.htm